Prestige Consumer Healthcare Inc.

NYQ: PBH
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Prestige Consumer Healthcare Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get PBH Z-Score →

About Prestige Consumer Healthcare Inc.

Healthcare Drug Manufacturers - Specialty & Generic
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

📊 Fundamental Analysis

Prestige Consumer Healthcare Inc. demonstrates a healthy profit margin of 16.9%.

The company recently reported -2.4% revenue growth, which is negative, indicating a recent decline in revenue.

Return on Equity (ROE) is 10.3%, which suggests room for improvement in capital utilization.

At a current price of $56.55, PBH currently trades near the bottom of its 52-week range (14%), indicating potential value or weakness (Range: $51.24 - $89.37).

💰 Valuation Insight

PBH trades at a 40.3% discount (PE: 14.92), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

⚠️ Profit Margin Moderate
⚠️ Debt/Equity Moderate
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
Beta (Risk) Low Volatility

Key Financials

Market Cap
$2.72B
Trailing P/E
14.92
Forward P/E
11.76
Beta (5Y)
0.47
52W High
$89.37
52W Low
$51.24
Avg Volume
480K
Day High
Day Low
Get PBH Z-Score on Dashboard 🚀